Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients

NCT00751608 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Familial Hypercholesterolemia

Interventions

DRUG: APL180
DRUG: APL180
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals